With the recent advancement of proto-oncogene testing and immunohistochemical staining, treatment for GIST has evolved with therapies directed against specific kit/PDGFRA proto-oncogene, showing promising results. The gene discussed is KIT; the disease is gastrointestinal stromal tumor.